Autoimmune Hepatitis Study

NCT00286663 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2008-07-09

No results posted yet for this study

Summary

The purpose of the study is to determine the role special antibodies play in possibly identifying Autoimmune Hepatitis through the following:

Identify the response of specific T cells to antibodies and Monitor the response of the cells that regulate the immune system

Conditions

  • Hepatitis, Autoimmune

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH
  • University of Rochester

    lead OTHER

Principal Investigators

  • Parvez S Mantry, MD · University of Rochester

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-01-31
Completion
2008-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00286663 on ClinicalTrials.gov